Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 120
Summary
- Conditions
- Coronaviridae Infections
- Coronavirus Infection
- Nidovirales Infections
- Respiratory Tract Disease
- Respiratory Tract Infections
- RNA Virus Infections
- SARS (Severe Acute Respiratory Syndrome)
- Virus Diseases
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04476979
- Collaborators
- Institut National de la Santé Et de la Recherche Médicale, France
- Investigators
- Not Provided